Third Biennial Symposium on Biology, Diagnosis and Treatment of Lymphomas
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: August 15, 2005
Conference Dates: Friday, October 14, 2005
Conference Location: Marriott West, West Conshohocken, PA
Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania
Conference Brochure: Download PDF version of conference brochure.
Topics Covered: Non-Hodgkins, Hodgkins, Prognostic Markers, New Targeted Therapies
Conference Objectives: At the completion of this conference, participants should be able to:
- Discuss the current classification of lymphomas as well as the controversies in diagnosis and their impact on management;
- Gain new insight into pathogenesis of lymphomas;
- Appreciate the growing role of understanding the basic mechanisms of the disease in diagnosis and treatment of lymphomas;
- Critically assess novel diagnostic and therapeutic approaches to lymphomas
Who Should Attend: Clinical Oncologists, Pathologists, Hematopathologists, Oncology Nurses and other health care professional involved in the treatment of patients with lymphoma
- Welcome and Introduction: John Glick
- Classification of lymphomas: Dale Frank
- Biology of non-Hodgkin’s lymphomas: diagnostic and therapeutic implications: Mariusz A. Wasik
- Biology of Hodgkin lymphoma: Harald Stein (Free Univ. Berlin) 9:40- 9:55 Questions and Answers
- Proteomic analysis of aberrant cell signaling in lymphomas: Kojo Elenitoba-Johnson (Univ. of Utah)
- Prognostic markers in small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL): Adam Bagg
- siRNA expression profile of SLL/CLL: Carlo Croce (Ohio State)
- Glucose metabolism by lymphoma cells: diagnostic and therapeutic implications: Rebecca Ellstrom (Univ. of Michigan)
- Antibody-based therapy of lymphomas: John Leonard (Weill/Cornell)
- Histone deactehylase inhibitors in treatment of lymphomas: Ellen Kim
- Targeted therapies for SLL/CLL: John Byrd (Ohio State)
- Targeted therapies for non SLL/CLL small B-cell lymphomas: Stephen Schuster
- New therapeutic agents for aggressive B-cell lymphoma: Sunita Nasta
- Closing remarks: Mariusz Wasik/Stephen Schuster
Registration Information: For more information, or to request a brochure, please contact Mary Graham at 215-662-7328 or email@example.com.
Conference Fees: $175.00 physician, $95.00 nurses and other health care professionals, No fee for faculty, staff, fellows & students of the University of Pennsylvania
All fields are required.
Make checks payable to: Trustees, University of Pennsylvania. Mail payment and registration to:
Abramson Cancer Center of the University of Pennsylvania
3400 Spruce St. - 16 Penn Tower
Philadelphia, PA 19104-4283
P: 215-662-7328 • F: 215-614-1854
Continuing Education: Yes. The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Frequently Asked Questions
National Cancer Institute
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!